Brief: Inozyme Pharma Reports First Quarter 2022 Financial Results And Provides Business Highlights

Inozyme Pharma

10/05/2022 12:32

May 10 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS HIGHLIGHTS
    * Q1 LOSS PER SHARE $0.71
    * PRELIMINARY BIOMARKER AND SAFETY DATA FROM ONGOING PHASE
1/2
TRIAL OF INZ-701 IN ABCC6 DEFICIENCY ON TRACK FOR Q2 OF 2022
    * NET LOSS WAS $16.9 MILLION, OR $0.71 LOSS PER SHARE, FOR
THE
QUARTER ENDED MARCH 31, 2022
    * Q1 EARNINGS PER SHARE VIEW $-0.82 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7WVppw 
Further company coverage:  INZY.O 

 ((Reuters.Briefs@thomsonreuters.com;))